Bexion Pharmaceuticals announces significant regulatory milestone toward Phase 2 cancer trial
Covington-based Bexion Pharmaceuticals, Inc. an oncology-focused company, Tuesday announced the completion of a Type B End-of-Phase 1 meeting with the…
Glioblastoma Multiforme
Read More